Clinical Trial Update: Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a cytomegalovirus vaccine therapy in cancer patients after donor stem cell transplant who have CMV infection refractory to standard the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cytomegalovirus Infection

Drugs mentioned

• Cytomegalovirus vaccine therapy

Snippet

Sponsor: University of Louisville | Conditions: Cancer | Phase 1 | Status: COMPLETED